Allison Schwartz's Insider Trades & SAST Disclosures
Allison Schwartz's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 369 Restricted Stock Units done . Disclosure was reported to the exchange on Sept. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Allison Schwartz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 369 | 369 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 74 | 1,250 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 74 | 224 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 56 | 1,332 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 56 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 44 | 1,297 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 44 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 42 | 1,257 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 42 | 84 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.31 per share. | 01 Sep 2024 | 35 | 1,215 (0%) | 0% | 337.3 | 11,806 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 31 | 1,268 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 31 | 31 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.30 per share. | 01 Sep 2024 | 27 | 1,305 (0%) | 0% | 334.3 | 9,026 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.33 per share. | 01 Sep 2024 | 21 | 1,276 (0%) | 0% | 337.3 | 7,084 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.30 per share. | 01 Sep 2024 | 20 | 1,237 (0%) | 0% | 337.3 | 6,746 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.33 per share. | 01 Sep 2024 | 15 | 1,253 (0%) | 0% | 337.3 | 5,060 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 3,996 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 3,939 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 298 | 298 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 82 | 1,210 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 82 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 56 | 1,151 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 56 | 56 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 44 | 1,113 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 44 | 44 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 41 | 1,068 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 41 | 126 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.59 per share. | 01 Sep 2023 | 34 | 1,176 (0%) | 0% | 394.6 | 13,416 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 30 | 1,081 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 30 | 62 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.61 per share. | 01 Sep 2023 | 23 | 1,128 (0%) | 0% | 394.6 | 9,076 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.61 per share. | 01 Sep 2023 | 18 | 1,095 (0%) | 0% | 394.6 | 7,103 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.59 per share. | 01 Sep 2023 | 17 | 1,051 (0%) | 0% | 394.6 | 6,708 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.58 per share. | 01 Sep 2023 | 12 | 1,069 (0%) | 0% | 394.6 | 4,735 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 3,890 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 82 | 82 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 82 | 1,014 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 80 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 80 | 1,060 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 56 | 955 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 56 | 112 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 43 | 917 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 43 | 88 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 34 | 980 (0%) | 0% | 478.3 | 16,263 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.33 per share. | 02 Sep 2022 | 33 | 1,027 (0%) | 0% | 478.3 | 15,785 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.30 per share. | 02 Sep 2022 | 23 | 932 (0%) | 0% | 478.3 | 11,001 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.33 per share. | 02 Sep 2022 | 18 | 899 (0%) | 0% | 478.3 | 8,610 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 167 | 167 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 30 | 92 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 30 | 886 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 12 | 874 (0%) | 0% | 486.3 | 5,835 | Bio-Rad A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges